Tobias J, Maglakelidze M, Andric Z, Ryspayeva D, et al. Phase II trial of HER-Vaxx, a B cell peptide-based vaccine, in HER2-overexpressing advanced gastric cancer patients under platinum-based chemotherapy (HERIZON). Clin Cancer Res 2024 Jul 19. doi: 10.1158/1078-0432.CCR-24-0742.
PMID: 39028916